Département de Médecine Générale, Nantes Université, Nantes, France.
SPHERE, UMR INSERM 1246, Nantes Université, Université de Tours, Nantes, France.
Basic Clin Pharmacol Toxicol. 2024 Jan;134(1):116-120. doi: 10.1111/bcpt.13908. Epub 2023 Jun 15.
Two deprescribing search filters for MEDLINE and one deprescribing search filter for Embase have been recently developed, including objectively developed search filters. The objective of this case study was to implement these three deprescribing search filters in systematic review (SR) search strategies and to assess their effect on performances. SR that independently developed original search strategies (OSS) were selected. The deprescribing filters were implemented in each OSS, generating two implemented search strategies (ISS1 and ISS2) in MEDLINE and one ISS (ISS3) in Embase. OSS were re-run on the same date as ISS. The performances of ISS and OSS were calculated and compared. Two SR were included (SR1 and SR2). For MEDLINE, SR1 included 12 articles. The sensitivity was 50% for OSS, 58% for ISS1 and 42% for ISS2. SR2 included four articles. The sensitivity of OSS, ISS 1 and 2 was 25%. For Embase, SR1 included 12 articles. The sensitivity was 33% for OSS and 58% for ISS3. SR2 included four articles. None of the four included articles were retrieved with OSS or ISS3. While sensitivity of OSS was moderate, the objectively developed deprescribing filters maintained or slightly improved this sensitivity when implementing.
最近开发了两种针对 MEDLINE 的减药搜索过滤器和一种针对 Embase 的减药搜索过滤器,其中包括客观开发的搜索过滤器。本案例研究的目的是在系统评价(SR)搜索策略中实施这三种减药搜索过滤器,并评估它们对性能的影响。选择了独立开发原始搜索策略(OSS)的 SR。在每个 OSS 中实施减药过滤器,在 MEDLINE 中生成两种实施的搜索策略(ISS1 和 ISS2),在 Embase 中生成一种 ISS(ISS3)。OSS 于与 ISS 相同的日期重新运行。计算并比较 ISS 和 OSS 的性能。纳入了两项 SR(SR1 和 SR2)。对于 MEDLINE,SR1 包括 12 篇文章。OSS 的灵敏度为 50%,ISS1 的灵敏度为 58%,ISS2 的灵敏度为 42%。SR2 包括四篇文章。OSS、ISS1 和 ISS2 的灵敏度为 25%。对于 Embase,SR1 包括 12 篇文章。OSS 的灵敏度为 33%,ISS3 的灵敏度为 58%。SR2 包括四篇文章。OSS 或 ISS3 均未检索到这四篇文章。虽然 OSS 的灵敏度为中等,但当实施客观开发的减药过滤器时,其灵敏度保持或略有提高。